Correlation Between Qualigen Therapeutics and 4 Less

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and 4 Less at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and 4 Less into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and 4 Less Group, you can compare the effects of market volatilities on Qualigen Therapeutics and 4 Less and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of 4 Less. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and 4 Less.

Diversification Opportunities for Qualigen Therapeutics and 4 Less

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Qualigen and FLES is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and 4 Less Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4 Less Group and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with 4 Less. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4 Less Group has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and 4 Less go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and 4 Less

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the 4 Less. But the stock apears to be less risky and, when comparing its historical volatility, Qualigen Therapeutics is 2.69 times less risky than 4 Less. The stock trades about -0.04 of its potential returns per unit of risk. The 4 Less Group is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  220.00  in 4 Less Group on August 29, 2024 and sell it today you would lose (219.98) from holding 4 Less Group or give up 99.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.8%
ValuesDaily Returns

Qualigen Therapeutics  vs.  4 Less Group

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
4 Less Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 4 Less Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, 4 Less is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Qualigen Therapeutics and 4 Less Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and 4 Less

The main advantage of trading using opposite Qualigen Therapeutics and 4 Less positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, 4 Less can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4 Less will offset losses from the drop in 4 Less' long position.
The idea behind Qualigen Therapeutics and 4 Less Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency